Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Br J Cancer ; 97(3): 315-21, 2007 Aug 06.
Artigo em Inglês | MEDLINE | ID: mdl-17622246

RESUMO

Epithelial cell adhesion molecule EpCAM is a transmembrane glycoprotein that is frequently overexpressed in a variety of carcinomas. This pan-carcinoma antigen has served as the target for a plethora of immunotherapies. Innovative therapeutic approaches include the use of trifunctional antibodies (trAbs) that recruit and activate different types of immune effector cells at the tumour site. The trAb catumaxomab has dual specificity for EpCAM and CD3. In patients with malignant ascites, catumaxomab significantly increased the paracentesis-free interval, corroborating the high efficacy of this therapeutic antibody. Here, we characterised the monoclonal antibody (mAb) HO-3, that is, the EpCAM-binding arm of catumaxomab. Peptide mapping indicated that HO-3 recognises a discontinuous epitope, having three binding sites in the extracellular region of EpCAM. Studies with glycosylation-deficient mutants showed that mAb HO-3 recognised EpCAM independently of its glycosylation status. High-affinity binding was not only detected for mAb HO-3, but also for the monovalent EpCAM-binding arm of catumaxomab with an excellent K(D) of 5.6 x 10(-10) M. Furthermore, trAb catumaxomab was at least a 1000-fold more effective in eliciting the eradication of tumour cells by effector peripheral blood mononuclear cells compared with mAb HO-3. These findings suggest the great therapeutic potential of trAbs and clearly speak in favour of EpCAM-directed cancer immunotherapies.


Assuntos
Antígenos de Neoplasias/uso terapêutico , Moléculas de Adesão Celular/uso terapêutico , Imunoterapia , Neoplasias/terapia , Sequência de Aminoácidos , Anticorpos Biespecíficos/metabolismo , Antígenos de Neoplasias/química , Antígenos de Neoplasias/imunologia , Antígenos de Neoplasias/metabolismo , Sequência de Bases , Moléculas de Adesão Celular/química , Moléculas de Adesão Celular/imunologia , Moléculas de Adesão Celular/metabolismo , Linhagem Celular Tumoral , Primers do DNA , Fator de Crescimento Epidérmico/química , Fator de Crescimento Epidérmico/metabolismo , Molécula de Adesão da Célula Epitelial , Epitopos/química , Glicosilação , Humanos , Dados de Sequência Molecular
3.
Acta Med Austriaca ; 2(4): 105-10, 1975.
Artigo em Alemão | MEDLINE | ID: mdl-1224926

RESUMO

The possibilities of medicamental antirheumatic treatment, are reviewed. Drugs are divided in nonsteroidal antirheumatic drugs, corticoids and combined drugs, so called basic treatment, and locally administered drugs. Mechanisms of action, indication, and effects of those groups are discussed and literature is briefly reviewed.


Assuntos
Artrite Reumatoide/tratamento farmacológico , Ouro/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Cloroquina/uso terapêutico , Cortisona/análogos & derivados , Humanos , Imunossupressores/uso terapêutico , Penicilamina/uso terapêutico , Psicotrópicos/uso terapêutico
7.
Z Allgemeinmed ; 49(7): 295-9, 1973 Mar 10.
Artigo em Alemão | MEDLINE | ID: mdl-4782776
13.
Wien Klin Wochenschr ; 81(1): 1-8, 1969 Jan 03.
Artigo em Alemão | MEDLINE | ID: mdl-5773238
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA